Maria Coakley

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Annals of Oncology · 2022 · 191 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Survival following allogeneic transplant in patients with myelofibrosis

Krisstina Gowin, Karen K. Ballen, Kwang Woo Ahn et al. · Blood Advances · 2020 · 97 citations · Full text

Medicine, Hematology, Stem Cell Transplantation +11

Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer

Maria Coakley, Guillermo Villacampa, Prithika Sritharan et al. · Clinical Cancer Research · 2023 · 44 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Association of post-operative ctDNA detection with outcomes of patients with early breast cancers

Rosalind Cutts, Lara Ulrich, Matthew Beaney et al. · ESMO Open · 2024 · 24 citations · Full text

Medicine, Oncology, Radiology +13

Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Cancer Research · 2022 · 14 citations

Medicine, Molecular Medicine, Oncology +17